Sriram K, Insel PA. G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol Pharmacol. 2018;93:251–8.
Article PubMed PubMed Central CAS Google Scholar
Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9:88.
Article PubMed PubMed Central CAS Google Scholar
Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov. 2017;16:829–42.
Article PubMed PubMed Central CAS Google Scholar
Chung S, Funakoshi T, Civelli O. Orphan GPCR research. Br J Pharmacol. 2008;153:S339–S346.
Article PubMed CAS Google Scholar
Tang XL, Wang Y, Li DL, Luo J, Liu MY. Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets. Acta Pharmacol Sin. 2012;33:363–71.
Article PubMed PubMed Central CAS Google Scholar
Stockert JA, Devi LA. Advancements in therapeutically targeting orphan GPCRs. Front Pharmacol. 2015;6:138138.
Watkins LR, Orlandi C. In vitro profiling of orphan G protein coupled receptor (GPCR) constitutive activity. Br J Pharmacol. 2021;178:2963–75.
Article PubMed CAS Google Scholar
Lu SM, Jang W, Inoue A, Lambert NA. Constitutive G protein coupling profiles of understudied orphan GPCRs. PLoS One. 2021;16:e0247743.
Article PubMed PubMed Central CAS Google Scholar
Leurs R, Smit MJ, Alewijnse AE, Timmerman H. Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem Sci. 1998;23:418–22.
Article PubMed CAS Google Scholar
Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrin Met. 2002;13:336–43.
Allen LF, Lefkowitz RJ, Caron MG, Cotecchia S. G-protein-coupled receptor genes as protooncogenes - constitutively activating mutation of the alpha-1b-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA. 1991;88:11354–8.
Article PubMed PubMed Central CAS Google Scholar
Tao YX. Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics. Pharmacol Ther. 2008;120:129–48.
Article PubMed PubMed Central CAS Google Scholar
Hase M, Yokomizo T, Shimizu T, Nakamura M. Characterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates G(i) proteins. J Biol Chem. 2008;283:12747–55.
Article PubMed CAS Google Scholar
Iida K, Ahmed AHA, Nagatsuma AK, Shibutani T, Yasuda S, Kitamura M, et al. Identification and therapeutic targeting of GPR20, selectively expressed in gastrointestinal stromal tumors, with DS-6157a, a first-in-class antibody-drug conjugate. Cancer Discov. 2021;11:1508–23.
Article PubMed CAS Google Scholar
Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004;22:3813–25.
Article PubMed CAS Google Scholar
George S, Heinrich MC, Somaiah N, Van Tine BA, McLeod R, Laadem A, et al. A phase 1, multicenter, open-label, first-in-human study of DS-6157a in patients (pts) with advanced gastrointestinal stromal tumor (GIST). Clin Cancer Res. 2023;29:3659–67.
Article PubMed PubMed Central CAS Google Scholar
Klug LR, Khosroyani HM, Kent JD, Heinrich MC. New treatment strategies for advanced-stage gastrointestinal stromal tumours. Nat Rev Clin Oncol. 2022;19:328–41.
Galandrin S, Oligny-Longpré G, Bouvier M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci. 2007;28:423–30.
Article PubMed CAS Google Scholar
Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9:373–86.
Article PubMed PubMed Central CAS Google Scholar
Toyooka M, Tujii T, Takeda S. The N-terminal domain of GPR61, an orphan G-protein-coupled receptor, is essential for its constitutive activity. J Neurosci Res. 2009;87:1329–33.
Article PubMed CAS Google Scholar
Ersoy BA, Pardo L, Zhang SM, Thompson DA, Millhauser G, Govaerts C, et al. Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nat Chem Biol. 2012;8:725–30.
Article PubMed PubMed Central CAS Google Scholar
Coleman JU, Ngo T, Smith NJ. The G protein-coupled receptor N-terminus and receptor signalling: N-tering a new era. Cell Signal. 2017;33:1–9.
Article PubMed CAS Google Scholar
Zhang H, Chu G, Wang G, Yao M, Lu S, Chen T. Mechanistic understanding of the palmitoylation of Go protein in the allosteric regulation of adhesion receptor GPR97. Pharmaceutics. 2022;14:1856.
Article PubMed PubMed Central CAS Google Scholar
Hilger D, Masureel M, Kobilka BK. Structure and dynamics of GPCR signaling complexes. Nat Struct Mol Biol. 2018;25:4–12.
Article PubMed PubMed Central CAS Google Scholar
Dokholyan NV. Controlling allosteric networks in proteins. Chem Rev. 2016;116:6463–87.
Article PubMed CAS Google Scholar
Wright SC, Lukasheva V, Le Gouill C, Kobayashi H, Breton B, Mailhot-Larouche S, et al. BRET-based effector membrane translocation assay monitors GPCR-promoted and endocytosis-mediated Gq activation at early endosomes. Proc Natl Acad Sci USA. 2021;118:e2025846118.
Article PubMed PubMed Central CAS Google Scholar
Zhao LH, Yuan QN, Dai AT, He XH, Chen CW, Zhang C, et al. Molecualr recognition of two endogenous hormones by the human parathyroid hormone receptor-1. Acta Pharmacol Sin. 2023;44:1227–37.
Article PubMed CAS Google Scholar
Mizumura T, Kondo K, Kurita M, Kofuku Y, Natsume M, Imai S, et al. Activation of adenosine A2A receptor by lipids from docosahexaenoic acid revealed by NMR. Sci Adv. 2020;6:eaay8544.
Article PubMed PubMed Central CAS Google Scholar
Dror RO, Arlow DH, Maragakis P, Mildorf TJ, Pan AC, Xu HF, et al. Activation mechanism of the β2-adrenergic receptor. Proc Natl Acad Sci USA. 2011;108:18684–9.
Article PubMed PubMed Central CAS Google Scholar
S
留言 (0)